or Try an Advanced Search...

    Antimicrobial Resistance Stocks List

    Symbol Grade Name % Change
    SPRO C Spero Therapeutics, Inc. 1.20
    OPGN D OpGen, Inc. -2.43
    MCRB F Seres Therapeutics, Inc. 37.44
    MTNB F Matinas Biopharma Holdings, Inc. -0.45
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research
    Related Stock Lists: Antibiotics Bacterial Infections Biopharmaceutical Evolutionary Biology Medicine Multi Drug Resistant Bacterial Infections Veterinary Medicine Aminoglycoside Autoimmune Disease Bacteria Bioinformatics Cdi Clinical Development Clostridioides Difficile Clostridium Difficile Clostridium Difficile Infection Colitis Diarrhea Digestive Diseases Drug Resistance

    Related ETFs - A few ETFs which own one or more of the above listed Antimicrobial Resistance stocks.

    Symbol Grade Name Weight
    BTEC D Principal Healthcare Innovators Index ETF 0.08
    IWC C iShares Microcap ETF 0.05
    IWO D iShares Russell 2000 Growth ETF 0.01
    HDG A ProShares Hedge Replication ETF 0.0
    IWM C iShares Russell 2000 ETF 0.0
    View all Antimicrobial Resistance ETFs...
    Compare ETFs
    Compare BTEC to HDG Compare BTEC to IWC Compare HDG to IWM

        Antimicrobial Resistance Stocks Recent News

        Date Stock Title
        May 9 MCRB Seres Therapeutics First Quarter 2024 Earnings: US$0.28 loss per share (vs US$0.56 loss in 1Q 2023)
        May 9 MCRB Seres Therapeutics Inc (MCRB) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
        May 8 MCRB Seres Therapeutics Reports Q1 2024 Earnings: Surpasses Revenue Estimates
        May 8 SPRO Spero Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on Wednesday, May 15, 2024
        May 8 MCRB Seres Therapeutics GAAP EPS of -$0.27 beats by $0.07
        May 8 MCRB Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
        May 7 MCRB Seres Therapeutics Q1 2024 Earnings Preview
        May 6 MCRB Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024
        Related Industries: Biotechnology Diagnostics & Research
        Related Stock Lists: Antibiotics Bacterial Infections Biopharmaceutical Evolutionary Biology Medicine Multi Drug Resistant Bacterial Infections Veterinary Medicine Aminoglycoside Autoimmune Disease Bacteria Bioinformatics Cdi Clinical Development Clostridioides Difficile Clostridium Difficile Clostridium Difficile Infection Colitis Diarrhea Digestive Diseases Drug Resistance
        Antimicrobial Resistance

        Antimicrobial resistance (AMR) is the ability of a microorganism (such as bacteria, viruses, and some parasites) to resist the effects of medication that once could successfully treat the microorganism. When this happens, standard treatments become ineffective, infections persist and may spread to others.

        Browse All Tags